Analysis of Tumor Proliferation Markers in Early-Stage Luminal Breast Cancer: A Comprehensive Study Using Mitotic Activity Index, Ki-67, and Phosphohistone H3 Expression
International Journal of Surgical Pathology · 2025-06 · 33 (4) · 882-890
DOI: 10.1177/10668969241295355 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgical Pathology, online erschienen am 15.11.2024. Verfasst von P Jamshiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Ki-67 Antigen, Mitotic Index, Histones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Jawaharlal Institute Of Postgraduate Medical Education and Research.
Abstract (Originalsprache)
Introduction and Aim: Routinely used proliferation markers such as mitotic activity index (MAI) and Ki-67 index show limited reproducibility due to high interobserver variability in breast cancer assessment. Phosphohistone H3 (PhH3), a novel proliferation marker, is gaining attention in breast cancer research. This study aimed to evaluate the inter-rater agreement among MAI, Ki-67, and PhH3 expressions in early-stage luminal breast cancer and assess the impact of replacing MAI with PhH3 index on tumor histological grading. Materials and Methods: Three pathologists assessed MAI, Ki-67, and PhH3 expressions in 66 early-stage luminal breast cancer specimens. Mitotic Activity Index was scored based on mitotic figures in an area of 2 mm 2 while Ki-67 index utilized a 14% threshold for positively stained nuclei. Phosphohistone H3 expression cutoff was set at 13 positive cells per 2 mm 2 . The inter-rater agreement for the 3 variables was analyzed using Cohen kappa statistics.
Results
Among the 3 parameters, the kappa score of the PhH3 expression reflected very strong agreement between the 3 observers (κ = 0.991, 0.907, and 0.916). Only moderate agreement was noted for MAI (κ = 0.898, 0.562, and 0.592) and substantial agreement for Ki-67 index (κ = 0.869, 0.673, and 0.678). Moreover, replacing MAI with PhH3 index led to upgrade of histological grade in 15% to 16% of patients.
Conclusion
Our study demonstrated that PhH3 is a more reproducible proliferation marker than MAI and Ki-67. Incorporation of PhH3-based mitotic index in breast cancer grading might reduce the variation in the assessment of histological grade.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
- Department of General Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
- Department of Surgical Oncology, Sri Venkateswara Institute of Cancer Care and Advanced Research, Tirupati, India.
ORCID-Profile: Soundarya Ravi, Sree Rekha Jinkala
Förderung
- Jawaharlal Institute Of Postgraduate Medical Education and Research
Zitieren
APA
Jamshiya, P., Ravi, S., Hanuman, S. B., Jinkala, S. R., Jain, A., & Penumadu, P. (2025). Analysis of Tumor Proliferation Markers in Early-Stage Luminal Breast Cancer: A Comprehensive Study Using Mitotic Activity Index, Ki-67, and Phosphohistone H3 Expression. International Journal of Surgical Pathology, 33(4), 882-890. https://doi.org/10.1177/10668969241295355
Vancouver
Jamshiya P, Ravi S, Hanuman SB, Jinkala SR, Jain A, Penumadu P. Analysis of Tumor Proliferation Markers in Early-Stage Luminal Breast Cancer: A Comprehensive Study Using Mitotic Activity Index, Ki-67, and Phosphohistone H3 Expression. International Journal of Surgical Pathology. 2025;33(4):882-890. doi:10.1177/10668969241295355
BibTeX
@article{Jamshiya2025,
author = {Jamshiya, P and Ravi, Soundarya and Hanuman, Srinivas Bheemanathi and Jinkala, Sree Rekha and Jain, Ankit and Penumadu, Prasanth},
title = {Analysis of Tumor Proliferation Markers in Early-Stage Luminal Breast Cancer: A Comprehensive Study Using Mitotic Activity Index, Ki-67, and Phosphohistone H3 Expression},
journal = {International Journal of Surgical Pathology},
year = {2025},
volume = {33},
number = {4},
pages = {882--890},
doi = {10.1177/10668969241295355}
}
EUVIMED